Quick Links: Skip to main page content Skip to Search Skip to Topics Menu Skip to Common Links
  • Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail
  • Print
  • Share
  • E-mail
-
 
Pediatric Labeling Date:  01/10/2007
 
Trade Name:  Eloxatin
 
Generic Name or Proper Name (*):  oxaliplatin
 
Indications Studied:  Solid tumors
 
Label Changes Summary:  The effectiveness of oxaliplatin in children has not been established No significant activity observed in 2 Phase I and 2 Phase II trials in 159 patients ages 7 months to 22 years with solid tumors Information on clinical studies and AEs
 
Product Labeling:  Labeling  Opens a new window
 
BPCA(B):  B
 
Sponsor:  Sanofi-Aventis
 
Pediatric Exclusivity Granted Date:  09/27/2006
 
NNPS:  FALSE'
 
Therapeutic Category:  Antineoplastic
 
-
-